Literature DB >> 22243633

Enriched pathways for major depressive disorder identified from a genome-wide association study.

Chung-Feng Kao1, Peilin Jia, Zhongming Zhao, Po-Hsiu Kuo.   

Abstract

Major depressive disorder (MDD) has caused a substantial burden of disease worldwide with moderate heritability. Despite efforts through conducting numerous association studies and now, genome-wide association (GWA) studies, the success of identifying susceptibility loci for MDD has been limited, which is partially attributed to the complex nature of depression pathogenesis. A pathway-based analytic strategy to investigate the joint effects of various genes within specific biological pathways has emerged as a powerful tool for complex traits. The present study aimed to identify enriched pathways for depression using a GWA dataset for MDD. For each gene, we estimated its gene-wise p value using combined and minimum p value, separately. Canonical pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG) and BioCarta were used. We employed four pathway-based analytic approaches (gene set enrichment analysis, hypergeometric test, sum-square statistic, sum-statistic). We adjusted for multiple testing using Benjamini & Hochberg's method to report significant pathways. We found 17 significantly enriched pathways for depression, which presented low-to-intermediate crosstalk. The top four pathways were long-term depression (p⩽1×10-5), calcium signalling (p⩽6×10-5), arrhythmogenic right ventricular cardiomyopathy (p⩽1.6×10-4) and cell adhesion molecules (p⩽2.2×10-4). In conclusion, our comprehensive pathway analyses identified promising pathways for depression that are related to neurotransmitter and neuronal systems, immune system and inflammatory response, which may be involved in the pathophysiological mechanisms underlying depression. We demonstrated that pathway enrichment analysis is promising to facilitate our understanding of complex traits through a deeper interpretation of GWA data. Application of this comprehensive analytic strategy in upcoming GWA data for depression could validate the findings reported in this study.

Entities:  

Mesh:

Year:  2012        PMID: 22243633     DOI: 10.1017/S1461145711001891

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  23 in total

Review 1.  Genetic determinants of depression: recent findings and future directions.

Authors:  Erin C Dunn; Ruth C Brown; Yael Dai; Jonathan Rosand; Nicole R Nugent; Ananda B Amstadter; Jordan W Smoller
Journal:  Harv Rev Psychiatry       Date:  2015 Jan-Feb       Impact factor: 3.732

Review 2.  The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders.

Authors:  Jordan W Smoller
Journal:  Neuropsychopharmacology       Date:  2015-08-31       Impact factor: 7.853

3.  Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases.

Authors:  B Di Benedetto; R Rupprecht
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

4.  Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode.

Authors:  R Belzeaux; A Bergon; V Jeanjean; B Loriod; C Formisano-Tréziny; L Verrier; A Loundou; K Baumstarck-Barrau; L Boyer; V Gall; J Gabert; C Nguyen; J-M Azorin; J Naudin; E C Ibrahim
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

5.  A comprehensive network and pathway analysis of candidate genes in major depressive disorder.

Authors:  Peilin Jia; Chung-Feng Kao; Po-Hsiu Kuo; Zhongming Zhao
Journal:  BMC Syst Biol       Date:  2011-12-23

6.  Orexin 1 Receptor Antagonism in the Basolateral Amygdala Shifts the Balance From Pro- to Antistress Signaling and Behavior.

Authors:  Jazmine D W Yaeger; Kevin T Krupp; Benjamin M Jacobs; Benard O Onserio; Brandon L Meyerink; Jacob T Cain; Patrick J Ronan; Kenneth J Renner; Ralph J DiLeone; Cliff H Summers
Journal:  Biol Psychiatry       Date:  2022-01-19       Impact factor: 12.810

7.  A genome-wide association study of a sustained pattern of antidepressant response.

Authors:  Aimee M Hunter; Andrew F Leuchter; Robert A Power; Bengt Muthén; Patrick J McGrath; Cathryn M Lewis; Ian A Cook; Holly A Garriock; Peter McGuffin; Rudolf Uher; Steven P Hamilton
Journal:  J Psychiatr Res       Date:  2013-05-30       Impact factor: 4.791

8.  Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder.

Authors:  Li-Chung Chuang; Chung-Feng Kao; Wei-Liang Shih; Po-Hsiu Kuo
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

9.  Incorporating Information of microRNAs into Pathway Analysis in a Genome-Wide Association Study of Bipolar Disorder.

Authors:  Wei-Liang Shih; Chung-Feng Kao; Li-Chung Chuang; Po-Hsiu Kuo
Journal:  Front Genet       Date:  2012-12-18       Impact factor: 4.599

10.  Association signals unveiled by a comprehensive gene set enrichment analysis of dental caries genome-wide association studies.

Authors:  Quan Wang; Peilin Jia; Karen T Cuenco; Zhen Zeng; Eleanor Feingold; Mary L Marazita; Lily Wang; Zhongming Zhao
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.